These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9019565)

  • 1. [Mutagenicity studies of montirelin hydrate (NS-3)].
    Iwakura K; Tamura H; Yamashita Y; Kitayama E; Hamasu Y; Nagasawa H; Watanabe M; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():325-34. PubMed ID: 9019565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutagenicity studies of lactitol (NS-4)].
    Iwakura K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():487-97. PubMed ID: 7837301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Otsuka M; Kajiwara Y; Ajimi S; Shimazaki H; Kikuno T; Ogura S; Inai T; Kakimoto K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():251-61. PubMed ID: 9170613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].
    Iwakura K; Tamura H; Yamashita Y; Watanabe M; Sumi N; Shindo Y; Ando M; Kojima M
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():241-57. PubMed ID: 8709165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Tamura H; Yamashita Y; Kitayama E; Iwakura K; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A mutagenicity study of calcipotriol (MC903)].
    Kitagaki T; Oguma Y; Yokota F; Ono M; Shirakawa K; Nagata M; Konishi R
    J Toxicol Sci; 1996 Jul; 21 Suppl 2():465-74. PubMed ID: 8741426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
    Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
    J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity studies with palm fruit carotene.
    Masuda M; Haresaku M; Takei T; Nakamura T
    J Toxicol Sci; 1995 Nov; 20(5):619-27. PubMed ID: 8720168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
    Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R
    J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity tests on propiverine hydrochloride.
    Ohuchida A; Furukawa A
    J Toxicol Sci; 1989 May; 14(2):131-41. PubMed ID: 2778853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutagenicity studies of prednisolone farnesylate (PNF)].
    Otsuka M; Ajimi S; Kajiwara Y; Ogura S; Kakimoto K; Inai T; Tanaka H; Ohuchida A
    J Toxicol Sci; 1992 Nov; 17 Suppl 3():269-81. PubMed ID: 1293327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
    Jin SE; Lee MY; Seo CS; Ha H; Kim JY; Shin HK
    J Ethnopharmacol; 2017 Apr; 202():122-126. PubMed ID: 27916588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxicity and mutagenicity studies of T-3761].
    Nakamura S; Hayashi T; Nojima Y; Nishida N; Kawamura Y; Kodama T
    Jpn J Antibiot; 1995 Jun; 48(6):868-77. PubMed ID: 7666585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Ohuchida A; Kouchi Y; Sato S; Maeda Y
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity tests of polyoxyethylene hydrogenated castor oil 60 (HCO-60).
    Hirai O; Miyamae Y; Zaizen K; Miyamoto A; Takashima M; Hattori Y; Ohara K; Mine Y
    J Toxicol Sci; 1994 May; 19(2):89-96. PubMed ID: 8072043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity test of cefodizime sodium.
    Ohuchida A; Yoshida R
    J Toxicol Sci; 1988 Jun; 13 Suppl 1():245-56. PubMed ID: 3050144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity testing of sodium formononetin-3'-sulphonate (Sul-F) by assessing bacterial reverse mutation, chromosomal aberrations and micronucleus tests.
    Li C; Gao Y; Wang Y; Li G; Fan X; Li Y; Guo C; Tao J
    Regul Toxicol Pharmacol; 2017 Jun; 86():374-378. PubMed ID: 28408196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug.
    Ciaravino V; Kropko ML; Krishna G; Monteith DK; Theiss JC
    Mutat Res; 1992; 280(3):205-14. PubMed ID: 1381484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutagenicity studies of magnesium sulfate--reverse mutation test with bacteria and chromosomal aberration test with mammalian cells in culture].
    Oguma Y; Yokota F; Inoue K; Shimamura K
    J Toxicol Sci; 1998 May; 23 Suppl 1():81-90. PubMed ID: 9617738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.